Hjem › Ulcerøs kolitt
Kliniske studier for Ulcerøs kolitt rekrutterer i USA
79 studier for Ulcerøs kolitt rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- New York City, NY23 studier
- Orlando, FL22 studier
- Miami, FL21 studier
- Houston, TX17 studier
- San Antonio, TX16 studier
- Chicago, IL15 studier
- Tacoma, WA15 studier
- San Diego, CA15 studier
- Tyler, TX14 studier
- Colorado Springs, CO14 studier
- Los Angeles, CA13 studier
- St. Louis, MO13 studier
- Washington, DC12 studier
- Boston, MA11 studier
- Cincinnati, OH11 studier
- Providence, RI11 studier
- Louisville, KY10 studier
- Lewisville, TX10 studier
- Durham, NC10 studier
- Parma, OH10 studier
- Tampa, FL9 studier
- Lubbock, TX9 studier
- Evanston, IL9 studier
- Atlanta, GA9 studier
- Baltimore, MD8 studier
- Mountain View, CA8 studier
- Garland, TX8 studier
- Memphis, TN8 studier
- Round Rock, TX8 studier
- Scottsdale, AZ8 studier
- Metairie, LA8 studier
- Dallas, TX8 studier
- Cleveland, OH8 studier
- Seattle, WA8 studier
- Pittsburgh, PA7 studier
- Waukegan, IL7 studier
- Fort Worth, TX7 studier
- Charlotte, NC7 studier
- Anaheim, CA7 studier
- Wyoming, MI7 studier
Etter delstat
- Alabama7 studier
- Arizona19 studier
- Arkansas4 studier
- California39 studier
- Colorado17 studier
- Connecticut11 studier
- District of Columbia3 studier
- Florida31 studier
- Georgia14 studier
- Idaho4 studier
- Illinois24 studier
- Indiana10 studier
- Kansas10 studier
- Kentucky13 studier
- Louisiana15 studier
- Maryland13 studier
- Massachusetts16 studier
- Michigan17 studier
- Minnesota8 studier
- Mississippi6 studier
- Missouri16 studier
- Nevada6 studier
- New Hampshire5 studier
- New Jersey7 studier
- New York30 studier
- North Carolina23 studier
- Ohio26 studier
- Oklahoma4 studier
- Oregon5 studier
- Pennsylvania12 studier
- Rhode Island11 studier
- South Carolina12 studier
- South Dakota4 studier
- Tennessee12 studier
- Texas33 studier
- Utah7 studier
- Virginia14 studier
- Washington22 studier
- Wisconsin4 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
RekruttererObservasjonsstudie
Alder 18 til 85 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07619547Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07501078Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
RekruttererFase 3
Alle aldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06651281Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
RekruttererFase 4
Alder 18 til 80 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
RekruttererFase 3
Alder 2 til 17 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07071519Confirmatory Clinical Study in Active Ulcerative Colitis
RekruttererFase 2
Alder 16 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07296315A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
Alder 18 til 75 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07845487A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07463183A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06979336Immune Regulation in Ulcerative Colitis or Crohn s Disease
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
1 Day – 75 Years · Alle kjønn · Oppdatert 28. sep. 2026 · NCT00001184A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
RekruttererFase 3
Alder 3 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06663332A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
RekruttererFase 2/3
Alder 2 til 17 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RekruttererFase 3
Alder 18 til 70 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT03816345LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07186101A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
RekruttererFase 3
Alder 2 til 19 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT04844606LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
RekruttererFase 4
Alder 18 til 65 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06095128Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07513181Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.